Degasperi E - Search Results

1

Evaluation of three "beyond Baveno VI" criteria to safely spare endoscopies in compensated advanced chronic liver disease.

Tosetti G, Primignani M, La Mura V, D'Ambrosio R, Degasperi E, Mezzina N, Viganò M, Rumi M, Fracanzani AL, Lombardi R, Fargion S, Fraquelli M, Aghemo A, Lampertico P. Tosetti G, et al. Among authors: degasperi e. Dig Liver Dis. 2019 Aug;51(8):1135-1140. doi: 10.1016/j.dld.2018.12.025. Epub 2019 Jan 11. Dig Liver Dis. 2019. PMID: 30691777

2

Hyporesponsiveness to PegIFNα2B plus ribavirin in patients with hepatitis C-related advanced fibrosis.

Prati GM, Aghemo A, Rumi MG, D'Ambrosio R, De Nicola S, Donato MF, Degasperi E, Colombo M. Prati GM, et al. Among authors: degasperi e. J Hepatol. 2012 Feb;56(2):341-7. doi: 10.1016/j.jhep.2011.05.022. Epub 2011 Jul 12. J Hepatol. 2012. PMID: 21756847 Clinical Trial.

3

Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management.

Viganò M, Degasperi E, Aghemo A, Lampertico P, Colombo M. Viganò M, et al. Among authors: degasperi e. Expert Opin Biol Ther. 2012 Feb;12(2):193-207. doi: 10.1517/14712598.2012.646986. Epub 2011 Dec 22. Expert Opin Biol Ther. 2012. PMID: 22188392 Review.

4

Clinical drivers in naïve patient eligibility for treatment of chronic hepatitis C.

Degasperi E, Aghemo A. Degasperi E, et al. J Viral Hepat. 2012 Jan;19 Suppl 1:3-6. doi: 10.1111/j.1365-2893.2011.01517.x. J Viral Hepat. 2012. PMID: 22233407

5

Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C.

Aghemo A, Prati GM, Rumi MG, Soffredini R, D'Ambrosio R, Orsi E, De Nicola S, Degasperi E, Grancini V, Colombo M. Aghemo A, et al. Among authors: degasperi e. Hepatology. 2012 Nov;56(5):1681-7. doi: 10.1002/hep.25867. Epub 2012 Oct 14. Hepatology. 2012. PMID: 22619107 Clinical Trial.

6

Directly acting antivirals for the treatment of chronic hepatitis C: unresolved topics from registration trials.

Aghemo A, Degasperi E, Colombo M. Aghemo A, et al. Among authors: degasperi e. Dig Liver Dis. 2013 Jan;45(1):1-7. doi: 10.1016/j.dld.2012.05.002. Epub 2012 Jun 12. Dig Liver Dis. 2013. PMID: 22695478 Review.

7

Treatment of chronic hepatitis C with pegylated interferon-α in a patient with recurrent autoimmune thrombotic thrombocytopenic purpura.

Lotta LA, Degasperi E, Aghemo A, Ferrari B, Peyvandi F, Colombo M. Lotta LA, et al. Among authors: degasperi e. Transfus Med. 2013 Feb;23(1):66-68. doi: 10.1111/j.1365-3148.2012.01197.x. Epub 2012 Oct 29. Transfus Med. 2013. PMID: 23106108 No abstract available.

8

Allelic inhibition of displacement activity: a simplified one tube allele-specific PCR for evaluation of ITPA polymorphisms.

Galmozzi E, Facchetti F, Degasperi E, Aghemo A, Lampertico P. Galmozzi E, et al. Among authors: degasperi e. J Virol Methods. 2013 Feb;187(2):271-3. doi: 10.1016/j.jviromet.2012.11.026. Epub 2012 Nov 29. J Virol Methods. 2013. PMID: 23201294

9

Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection.

Oliviero B, Mele D, Degasperi E, Aghemo A, Cremonesi E, Rumi MG, Tinelli C, Varchetta S, Mantovani S, Colombo M, Mondelli MU. Oliviero B, et al. Among authors: degasperi e. J Hepatol. 2013 Jul;59(1):38-44. doi: 10.1016/j.jhep.2013.03.003. Epub 2013 Mar 14. J Hepatol. 2013. PMID: 23499727

10

PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year history.

Degasperi E, Viganò M, Aghemo A, Lampertico P, Colombo M. Degasperi E, et al. Expert Rev Anti Infect Ther. 2013 May;11(5):459-74. doi: 10.1586/eri.13.37. Expert Rev Anti Infect Ther. 2013. PMID: 23627852 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters